The Evaluation of Chronic Axonal Polyneuropathies

ABSTRACT

In this article, we present an easy-to-remember method of evaluating neuropathies. Our proposed method is based on asking four questions about the neuropathy and the patient: “What?,” “Where?,” “When?,” and “What setting?” Answering these questions helps characterize the neuropathy, and this characterization enables the clinician to develop a focused differential diagnosis and plan. After presenting this approach to evaluating neuropathy, we discuss many of the most common chronic axonal neuropathies in the context of this paradigm. Acquired demyelinating neuropathies and inherited neuropathies are discussed in other articles in this issue of Seminars in Neurology.

KEYWORDS

Peripheral neuropathy - polyneuropathy - axonal neuropathies

REFERENCES

• 1 England J D, Asbury A K. Peripheral neuropathy.  Lancet. 2004;  363 2151-2161
• 2 Hughes R A. Peripheral neuropathy.  BMJ. 2002;  324 466-469
• 3 Pourmand R. Evaluating patients with suspected peripheral neuropathy: do the right thing, not everything.  Muscle Nerve. 2002;  26 288-290
• 4 Lubec D, Mullbacher W, Finsterer J, Mamoli B. Diagnostic work-up in peripheral neuropathy: an analysis of 171 cases.  Postgrad Med J. 1999;  75 723-727
• 5 Burns J M, Mauermann M L, Burns T M. An easy approach to evaluating peripheral neuropathy.  J Fam Pract. 2006;  55 853-861
• 6 Dyck P J, Oviatt K F, Lambert E H. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis.  Ann Neurol. 1981;  10 222-226
• 7 Thomas P K, Marques Jr W, Davis M B et al.. The phenotypic manifestations of chromosome 17p11.2 duplication.  Brain. 1997;  120(Pt 3) 465-478
• 8 Dyck P J, Lais A C, Ohta M, Bastron J A, Okazaki H, Groover R V. Chronic inflammatory polyradiculoneuropathy.  Mayo Clin Proc. 1975;  50 621-637
• 9 Moulin D E, Hagen N, Feasby T E, Amireh R, Hahn A. Pain in Guillain-Barre syndrome.  Neurology. 1997;  48 328-331
• 10 Koike H, Mori K, Misu K et al.. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status.  Neurology. 2001;  56 1727-1732
• 11 Koike H, Mori K, Misu K et al.. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy.  Ann Neurol. 2003;  54 19-29
• 12 Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 [author's transl].  Diabete Metab. 1977;  3 97-107
• 13 Dalmau J, Graus F, Rosenblum M K, Posner J B. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients.  Medicine (Baltimore). 1992;  71 59-72
• 14 Camdessanche J P, Antoine J C, Honnorat J et al.. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients.  Brain. 2002;  125 166-175
• 15 Molinuevo J L, Graus F, Serrano C, Rene R, Guerrero A, Illa I. Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy.  Ann Neurol. 1998;  44 976-980
• 16 Tuck R R, McLeod J G. Autonomic dysfunction in Guillain-Barre syndrome.  J Neurol Neurosurg Psychiatry. 1981;  44 983-990
• 17 Burns T M, Lawn N D, Low P A, Camilleri M, Wijdicks E F. Adynamic ileus in severe Guillain-Barre syndrome.  Muscle Nerve. 2001;  24 963-965
• 18 Singh N K, Jaiswal A K, Misra S, Srivastava P K. Assessment of autonomic dysfunction in Guillain-Barre syndrome and its prognostic implications.  Acta Neurol Scand. 1987;  75 101-105
• 19 McLeod J G. Invited review: autonomic dysfunction in peripheral nerve disease.  Muscle Nerve. 1992;  15 3-13
• 20 Gertz M A, Merlini G, Treon S P. Amyloidosis and Waldenström's macroglobulinemia.  Hematology (Am Soc Hematol Educ Program). 2004;  257-282
• 21 Rajkumar S V, Gertz M A, Kyle R A. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy.  Am J Med. 1998;  104 232-237
• 22 Truax B T. Autonomic disturbances in the Guillain-Barre syndrome.  Semin Neurol. 1984;  4 462-468
• 23 Pareyson D. Charcot-Marie-Tooth disease and related neuropathies: molecular basis for distinction and diagnosis.  Muscle Nerve. 1999;  22 1498-1509
• 24 Kuhlenbaumer G. Mutations in SEPT9 cause hereditary neuralgic amyotrophy.  Nat Genet. 2005;  37 1044-1046
• 25 Burns T M, Phillips II L H, Dimberg E L, Vaught B K, Klein C J. Novel myelin protein zero mutation (Arg36Trp) in a patient with acute onset painful neuropathy.  Neuromuscul Disord. 2006;  16 308-310
• 26 Dyck P J. Horizons in Mayo Neurology and Neurosurgery: Perspectives on 100 Years and Future Trends. Rochester, MN; 2006
• 27 Albers J W, Kelly Jr J J. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features.  Muscle Nerve. 1989;  12 435-451
• 28 Albers J W, Donofrio P D, McGonagle T K. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy.  Muscle Nerve. 1985;  8 528-539
• 29 Ropper A H, Wijdicks E F, Shahani B T. Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barré syndrome.  Arch Neurol. 1990;  47 881-887
• 30 Gordon P H, Wilbourn A J. Early electrodiagnostic findings in Guillain-Barré syndrome.  Arch Neurol. 2001;  58 913-917
• 31 Dyck P J, Lambert E H. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies.  Arch Neurol. 1968;  18 603-618
• 32 Harris M I, Robbins D C. Prevalence of adult-onset IDDM in the U.S. population.  Diabetes Care. 1994;  17 1337-1340
• 33 Smith A G, Singleton J R. Idiopathic neuropathy, prediabetes and the metabolic syndrome.  J Neurol Sci. 2006;  242 9-14
• 34 Sinnreich M, Taylor B V, Dyck P J. Diabetic neuropathies. Classification, clinical features, and pathophysiological basis.  Neurologist. 2005;  11 63-79
• 35 Dyck P J, O'Brien P C, Litchy W J, Harper C M, Klein C J. Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy.  Diabetes Care. 2005;  28 2192-2200
• 36 Dyck P JB. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. AANEM Web site interview 2006. http://Available at: www.aanem.org/education/podcast/index.cfm Accessed November 1, 2006
• 37 Casey E B, Le Quesne P M. Digital nerve action potentials in healthy subjects, and in carpal tunnel and diabetic patients.  J Neurol Neurosurg Psychiatry. 1972;  35 612-623
• 38 Gilliatt R W, Willison R G. Peripheral nerve conduction in diabetic neuropathy.  J Neurol Neurosurg Psychiatry. 1962;  25 11-18
• 39 Singleton J R, Smith A G, Russell J W, Feldman E L. Microvascular complications of impaired glucose tolerance.  Diabetes. 2003;  52 2867-2873
• 40 Novella S P, Inzucchi S E, Goldstein J M. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy.  Muscle Nerve. 2001;  24 1229-1231
• 41 Singleton J R, Smith A G, Bromberg M B. Painful sensory polyneuropathy associated with impaired glucose tolerance.  Muscle Nerve. 2001;  24 1225-1228
• 42 Sumner C J, Sheth S, Griffin J W, Cornblath D R, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance.  Neurology. 2003;  60 108-111
• 43 Hoffman-Snyder C, Smith B E, Ross M A, Hernandez J, Bosch E P. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy.  Arch Neurol. 2006;  63 1075-1079
• 44 Singleton J R, Smith A G, Bromberg M B. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy.  Diabetes Care. 2001;  24 1448-1453
• 45 Dyck P J, Dyck P JB, Klein C J, Wiegand S D. Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study.  Muscle Nerve. 2007;  36(4) 536-541
• 46 Hughes R A, Umapathi T, Gray I A et al.. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy.  Brain. 2004;  127 1723-1730
• 47 Smith A G, Ramachandran P, Tripp S, Singleton J R. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy.  Neurology. 2001;  57 1701-1704
• 48 Said G, Boudier L, Selva J, Zingraff J, Drueke T. Different patterns of uremic polyneuropathy: clinicopathologic study.  Neurology. 1983;  33 567-574
• 49 Laaksonen S, Metsarinne K, Voipio-Pulkki L M, Falck B. Neurophysiologic parameters and symptoms in chronic renal failure.  Muscle Nerve. 2002;  25 884-890
• 50 Zochodne D W. Neuropathies associated with renal failure, hepatic disorders, chronic respiratory, and critical illness. Dyck PJ, Thomas PK Peripheral Neuropathy. 4th ed, vol 2. Philadelphia; Elsevier Saunders 2005: 2017-2038
• 51 Krishnan A V, Kiernan M C. Uremic neuropathy: clinical features and new pathophysiological insights.  Muscle Nerve. 2007;  35 273-290
• 52 Kiernan M C. Uremic neuropathy: clinical features and new pathophysiologic insights. AANEM Web site interview 2007. http://Available at: www.aanem.org/education/podcast/index.cfm Accessed June 1, 2007
• 53 Saperstein D S, Barohn R J. Polyneuropathy caused by nutritional and vitamin deficiency. In: Dyck PJ, Thomas PK Peripheral Neuropathy. 4th ed, vol 2. Philadelphia; Elsevier Saunders 2005: 2051-2062
• 54 Thaisetthawatkul P, Collazo-Clavell M L, Sarr M G, Norell J E, Dyck P J. A controlled study of peripheral neuropathy after bariatric surgery.  Neurology. 2004;  63 1462-1470
• 55 Herve C, Beyne P, Letteron P, Delacoux E. Comparison of erythrocyte transketolase activity with thiamine and thiamine phosphate ester levels in chronic alcoholic patients.  Clin Chim Acta. 1995;  234 91-100
• 56 Wang C, Crapo L M. The epidemiology of thyroid disease and implications for screening.  Endocrinol Metab Clin North Am. 1997;  26 189-218
• 57 Duyff R F, Van den Bosch J, Laman D M, van Loon B J, Linssen W H. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study.  J Neurol Neurosurg Psychiatry. 2000;  68 750-755
• 58 Dyck P J, Lambert E H. Polyneuropathy associated with hypothyroidism.  J Neuropathol Exp Neurol. 1970;  29 631-658
• 59 Lindenbaum J, Rosenberg I H, Wilson P W, Stabler S P, Allen R H. Prevalence of cobalamin deficiency in the Framingham elderly population.  Am J Clin Nutr. 1994;  60 2-11
• 60 Saperstein D S, Wolfe G I, Gronseth G S et al.. Challenges in the identification of cobalamin-deficiency polyneuropathy.  Arch Neurol. 2003;  60 1296-1301
• 61 Pratt R W, Weimer L H. Medication and toxin-induced peripheral neuropathy.  Semin Neurol. 2005;  25 204-216
• 62 Vrancken A F, Kalmijn S, Buskens E et al.. Feasibility and cost efficiency of a diagnostic guideline for chronic polyneuropathy: a prospective implementation study.  J Neurol Neurosurg Psychiatry. 2006;  77 397-401
• 63 Hill A B. The environment and disease: association or causation?.  Proc R Soc Med. 1965;  58 295-300
• 64 Burns T M, Shneker B F, Juel V C. Gasoline sniffing multifocal neuropathy.  Pediatr Neurol. 2001;  25 419-421
• 65 Brienza R S, Stein M D. Alcohol use disorders in primary care: do gender-specific differences exist?.  J Gen Intern Med. 2002;  17 387-397
• 66 Coulehan J L, Zettler-Segal M, Block M, McClelland M, Schulberg H C. Recognition of alcoholism and substance abuse in primary care patients.  Arch Intern Med. 1987;  147 349-352
• 67 Monforte R, Estruch R, Valls-Sole J, Nicolas J, Villalta J, Urbano-Marquez A. Autonomic and peripheral neuropathies in patients with chronic alcoholism. A dose-related toxic effect of alcohol.  Arch Neurol. 1995;  52 45-51
• 68 Zambelis T, Karandreas N, Tzavellas E, Kokotis P, Liappas J. Large and small fiber neuropathy in chronic alcohol-dependent subjects.  J Peripher Nerv Syst. 2005;  10 375-381
• 69 Mauermann M L, Klein C J, Orenstein R, Dyck P J. Disseminated sporotrichosis presenting with granulomatous inflammatory multiple mononeuropathies.  Muscle Nerve. 2007;  36(6) 866-872
• 70 Lauer G M, Walker B D. Hepatitis C virus infection.  N Engl J Med. 2001;  345 41-52
• 71 Authier F J, Bassez G, Payan C et al.. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy.  Neurology. 2003;  60 808-812
• 72 Santoro L, Manganelli F, Briani C et al.. Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population.  J Neurol Neurosurg Psychiatry. 2006;  77 626-629
• 73 Nemni R, Sanvito L, Quattrini A, Santuccio G, Camerlingo M, Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia.  J Neurol Neurosurg Psychiatry. 2003;  74 1267-1271
• 74 Apartis E, Leger J M, Musset L et al.. Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection?.  J Neurol Neurosurg Psychiatry. 1996;  60 661-666
• 75 Ferri C, La Civita L, Cirafisi C et al.. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations.  J Rheumatol. 1992;  19 889-895
• 76 Zaltron S, Puoti M, Liberini P. High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinaemia.  Ital J Gastroenterol Hepatol. 1998;  30 391-395
• 77 Gorevic P D. Cryopathies: cryoglobulins and cryofibrinogenemia. In: Frank MM, Austen KF, Claman HN, Unanue ER Samters Immunologic Diseases. 5th ed. Vol 2. Philadelphia; Little Brown 1995: 951-974
• 78 Kallemuchikkal U, Gorevic P D. Evaluation of cryoglobulins.  Arch Pathol Lab Med. 1999;  123 119-125
• 79 CDC Web site. http://Available at: www.cdc.gov Accessed March 4, 2007
• 80 Steere A C. Lyme disease.  N Engl J Med. 2001;  345 115-125
• 81 Thaisetthawatkul P, Logigian E L. Peripheral nervous system manifestations of Lyme borreliosis.  J Clin Neuromusc Dis. 2002;  3 165-171
• 82 Pachner A R, Steere A C. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.  Neurology. 1985;  35 47-53
• 83 Halperin J, Luft B J, Volkman D J, Dattwyler R J. Lyme neuroborreliosis. Peripheral nervous system manifestations.  Brain. 1990;  113(Pt 4) 1207-1221
• 84 Halperin J J. Lyme disease and the peripheral nervous system.  Muscle Nerve. 2003;  28 133-143
• 85 Hunninghake G W, Costabel U, Ando M et al.. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.  Sarcoidosis Vasc Diffuse Lung Dis. 1999;  16 149-173
• 86 Stern B J. Neurological complications of sarcoidosis.  Curr Opin Neurol. 2004;  17 311-316
• 87 Wiederholt W C, Siekert R G. Neurological manifestations of sarcoidosis.  Neurology. 1965;  15 1147-1154
• 88 Burns T M. Neurosarcoidosis.  Arch Neurol. 2003;  60 1166-1168
• 89 Stern B J, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations.  Arch Neurol. 1985;  42 909-917
• 90 Colover J. Sarcoidosis with involvement of the nervous system.  Brain. 1948;  71 451-475
• 91 Oksanen V. Neurosarcoidosis: clinical presentations and course in 50 patients.  Acta Neurol Scand. 1986;  73 283-290
• 92 Said G, Lacroix C, Plante-Bordeneuve V et al.. Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients.  Brain. 2002;  125 264-275
• 93 Burns T M, Dyck P J, Aksamit A J, Dyck P J. The natural history and long-term outcome of 57 limb sarcoidosis neuropathy cases.  J Neurol Sci. 2006;  244(1-2) 77-87
• 94 Hoitsma E, Drent M, Verstraete E et al.. Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis.  Clin Neurophysiol. 2003;  114 2326-2333
• 95 Hoitsma E, Faber C G, Drent M, Sharma O P. Neurosarcoidosis: a clinical dilemma.  Lancet Neurol. 2004;  3 397-407
• 96 Glynn N, Rhodes P. In National HIV Prevention Conference Atlanta; 2005
• 97 Verma A. Epidemiology and clinical features of HIV-1 associated neuropathies.  J Peripher Nerv Syst. 2001;  6 8-13
• 98 Dalakas M C. Peripheral neuropathy and antiretroviral drugs.  J Peripher Nerv Syst. 2001;  6 14-20
• 99 Brew B J. The peripheral nerve complications of human immunodeficiency virus (HIV) infection.  Muscle Nerve. 2003;  28 542-552
• 100 Brannagan III T H, McAlarney T, Latov N. Peripheral neuropathy in HIV-1 infection. In: Latov N, Wokke JH, Kelly JJ Jr Immunological and Infectious Diseases of the Nervous System. Cambridge, UK; Cambridge University Press 1998: 285-307
• 101 Roullet E, Assuerus V, Gozlan J et al.. Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases.  Neurology. 1994;  44 2174-2182
• 102 Gherardi R K, Chretien F, Delfau-Larue M H et al.. Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma.  Neurology. 1998;  50 1041-1044
• 103 Branson B M, Handsfield H H, Lampe M A et al.. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.  MMWR Recomm Rep. 2006;  55 1-17 , quiz CE1-4
• 104 Greenwald J L, Burstein G R, Pincus J, Branson B. A rapid review of rapid HIV antibody tests.  Curr Infect Dis Rep. 2006;  8 125-131
• 105 Roman G. Tropical myeloneuropathies revisited.  Curr Opin Neurol. 1998;  11 539-544
• 106 Thomas P K. Tropical neuropathies.  J Neurol. 1997;  244 475-482
• 107 Ooi W W, Srinivasan J. Leprosy and the peripheral nervous system: basic and clinical aspects.  Muscle Nerve. 2004;  30 393-409
• 108 Chad D A, Hedley-Whyte E T. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-2004. A 49-year-old woman with asymmetric painful neuropathy.  N Engl J Med. 2004;  350 166-176
• 109 Saleh A, Stone J H. Classification and diagnostic criteria in systemic vasculitis.  Best Pract Res Clin Rheumatol. 2005;  19 209-221
• 110 Schaublin G A, Michet Jr C J, Dyck P J, Burns T M. An update on the classification and treatment of vasculitic neuropathy.  Lancet Neurol. 2005;  4 853-865
• 111 Burns T M, Schaublin G A, Dyck P J. Vasculitic neuropathies.  Neurol Clin. 2007;  25 89-113
• 112 Jennette J C, Falk R J, Andrassy K et al.. Nomenclature of systemic vasculitides. Proposal of an international consensus conference.  Arthritis Rheum. 1994;  37 187-192
• 113 Langford C A. Vasculitis.  J Allergy Clin Immunol. 2003;  111 S602-S612
• 114 Vital C, Vital A, Canron M H et al.. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases.  J Peripher Nerv Syst. 2006;  11 20-29
• 115 Vollertsen R S, Conn D L, Ballard D J, Ilstrup D M, Kazmar R E, Silverfield J C. Rheumatoid vasculitis: survival and associated risk factors.  Medicine (Baltimore). 1986;  65 365-375
• 116 Dyck P J, Benstead T J, Conn D L, Stevens J C, Windebank A J, Low P A. Nonsystemic vasculitic neuropathy.  Brain. 1987;  110(Pt 4) 843-853
• 117 Said G, Lacroix C. Primary and secondary vasculitic neuropathy.  J Neurol. 2005;  252 633-641
• 118 Collins M P, Periquet M I. Non-systemic vasculitic neuropathy.  Curr Opin Neurol. 2004;  17 587-598
• 119 Dyck P J, Conn D L, Okazaki H. Necrotizing angiopathic neuropathy. Three-dimensional morphology of fiber degeneration related to sites of occluded vessels.  Mayo Clin Proc. 1972;  47 461-475
• 120 Collins M P, Mendell J R, Periquet M I et al.. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy.  Neurology. 2000;  55 636-643
• 121 Dyck P J, Windebank A J. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment.  Muscle Nerve. 2002;  25 477-491
• 122 Simmons Z, Feldman E L. Update on diabetic neuropathy.  Curr Opin Neurol. 2002;  15 595-603
• 123 Dyck P J, Norell J E, Dyck P J. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy.  Neurology. 1999;  53 2113-2121
• 124 Kaplan J G, Rosenberg R, Reinitz E, Buchbinder S, Schaumburg H H. Invited review: peripheral neuropathy in Sjögren's syndrome.  Muscle Nerve. 1990;  13 570-579
• 125 Fujibayashi T, Sugai S, Miyasaka N et al.. Revised Japanese diagnostic criteria for Sjögren's syndrome. Annual Report of Research Committee for Immune Disease. Toyko; Japanese Ministry of Health and Welfare 1999: 135-138
• 126 Vitali C, Bombardieri S, Jonsson R et al.. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.  Ann Rheum Dis. 2002;  61 554-558
• 127 Gorson K C, Ropper A H. Positive salivary gland biopsy, Sjögren syndrome, and neuropathy: clinical implications.  Muscle Nerve. 2003;  28 553-560
• 128 Mori K, Iijima M, Koike H et al.. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy.  Brain. 2005;  128 2518-2534
• 129 Mochizuki H, Kamakura K, Masaki T, Hirata A, Nakamura R, Motoyoshi K. Motor dominant neuropathy in Sjögren's syndrome: report of two cases.  Intern Med. 2002;  41 142-146
• 130 Gemignani F, Marbini A, Pavesi G et al.. Peripheral neuropathy associated with primary Sjögren's syndrome.  J Neurol Neurosurg Psychiatry. 1994;  57 983-986
• 131 Dyck P J. The clinical heterogeneity of immune sensory and autonomic neuropathies with (or without) sicca.  Brain. 2005;  128 2480-2482
• 132 Takahashi Y, Takata T, Hoshino M, Sakurai M, Kanazawa I. Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjögren's syndrome. IV immunoglobulin.  Neurology. 2003;  60 503-505
• 133 Mellgren S I, Conn D L, Stevens J C, Dyck P J. Peripheral neuropathy in primary Sjögren's syndrome.  Neurology. 1989;  39 390-394
• 134 Crow M K. Systemic lupus erythematosus. In: Goldman L, Ausiello D Cecil Textbook of Medicine. 23rd ed. Philadelphia; WB Saunders Company 2007: 2022-2031
• 135 Omdal R, Loseth S, Torbergsen T, Koldingsnes W, Husby G, Mellgren S I. Peripheral neuropathy in systemic lupus erythematosus-a longitudinal study.  Acta Neurol Scand. 2001;  103 386-391
• 136 Goransson L G, Tjensvoll A B, Herigstad A, Mellgren S I, Omdal R. Small-diameter nerve fiber neuropathy in systemic lupus erythematosus.  Arch Neurol. 2006;  63 401-404
• 137 D'Cruz D. Vasculitis in systemic lupus erythematosus.  Lupus. 1998;  7 270-274
• 138 Kyle R A, Therneau T M, Rajkumar S V et al.. Prevalence of monoclonal gammopathy of undetermined significance.  N Engl J Med. 2006;  354 1362-1369
• 139 International Myeloma Working Group . Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.  Br J Haematol. 2003;  121 749-757
• 140 Eurelings M, Lokhorst H M, Kalmijn S, Wokke J H, Notermans N C. Malignant transformation in polyneuropathy associated with monoclonal gammopathy.  Neurology. 2005;  64 2079-2084
• 141 Ropper A H, Gorson K C. Neuropathies associated with paraproteinemia.  N Engl J Med. 1998;  338 1601-1607
• 142 Latov N. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.  Ann Neurol. 1995;  37(S1) S32-S42
• 143 Kyle R A. Sequence of testing for monoclonal gammopathies.  Arch Pathol Lab Med. 1999;  123 114-118
• 144 Kyle R A. Monoclonal gammopathy of undetermined significance (MGUS): a review.  Clin Haematol. 1982;  11 123-150
• 145 Gertz M A, Rajkumar S V. Primary systemic amyloidosis.  Curr Treat Options Oncol. 2002;  3 261-271
• 146 Kissel J T, Mendell J R. Neuropathies associated with monoclonal gammopathies.  Neuromuscul Disord. 1996;  6 3-18
• 147 Oh S J, Gurtekin Y, Dropcho E J, King P, Claussen G C. Anti-Hu antibody neuropathy: a clinical, electrophysiological, and pathological study.  Clin Neurophysiol. 2005;  116 28-34
• 148 Lucchinetti C F, Kimmel D W, Lennon V A. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.  Neurology. 1998;  50 652-657
• 149 Amato A A, Collins M P. Neuropathies associated with malignancy.  Semin Neurol. 1998;  18 125-144
• 150 Graus F, Keime-Guibert F, Rene R et al.. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.  Brain. 2001;  124 1138-1148
• 151 Pittock S J, Kryzer T J, Lennon V A. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.  Ann Neurol. 2004;  56 715-719
• 152 Antoine J C, Cinotti L, Tilikete C et al.. [18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies.  Ann Neurol. 2000;  48 105-108
• 153 Rees J H, Hain S F, Johnson M R et al.. The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders.  Brain. 2001;  124 2223-2231
• 154 Burns T M, Ryan M M, Darras B, Jones Jr H R. Current therapeutic strategies for patients with polyneuropathies secondary to inherited metabolic disorders.  Mayo Clin Proc. 2003;  78 858-868
• 155 Barohn R J. Approach to peripheral neuropathy and neuronopathy.  Semin Neurol. 1998;  18 7-18
• 156 Lewis R A. Toxic and deficiency neuropathies. Continuum.  Lifelong Learning in Neurology. 2003;  9 160-181